U.S. Sen. Elizabeth Warren has asked the Federal Trade Commission “closely scrutinize” a $16.5 billion deal in which Novo Nordisk’s parent foundation would acquire Catalent, a leading ...
The transaction – first announced in February – would see Novo Nordisk's parent company Novo Holdings buy contract development and manufacturing organisation (CDMO) Catalent outright for $16.5 ...
Catalent, Inc. has a 12 month low of $31.80 and a 12 month high of $61.20. The company has a market cap of $10.86 billion, a price-to-earnings ratio of -9.84, a PEG ratio of 1.88 and a beta of 1. ...
Robert W. Baird analyst Eric Coldwell downgraded the rating on Catalent (CTLT – Research Report) to a Hold today, setting a price target of $63.50. Eric Coldwell has given his Hold rating due to ...
Some results have been hidden because they may be inaccessible to you